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Abstract 
 
Sexually transmitted infections (STI) occur worldwide with more than 340 million cases occurring 
annually in adults aged 15-49 years. The aim of the study is to determine the prevalence and              
co-existence of Chlamydia trachomatis and Herpes simplex virus (HSV) antibodies among students in 
a tertiary institution in Anambra State, Nigeria. This is a cross sectional descriptive study of the         
co–existence of Chlamydia trachomatis and HSV antibodies among students in a tertiary institution in 
Anambra State Nigeria carried out using enzyme immunoassay kits for determination of IgG class 
antibodies. The seroprevalence of HSV antibodies, (27.3%), was slightly higher than that of Chlamydia 
trachomatis, (21.6%) among the students.  Also more of the students, (18.2%) were positive to HSV 
antibodies only, when compared to 12.5% of them that were positive to Chlamydia trachomatis 
antibodies only, while 9.1% of them were seropositive to both organisms. The antibody titres to both 
organisms were found to be significantly higher among students with high risk sexual behaviours. 
The seroprevalence and co-existence of these organisms were high in both populations thus there is 
need to institute appropriate control measures to reduce the prevalence of these infections. 
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INTRODUCTION 
 
Sexually transmitted infections (STI) are a group of 
communicable infections that are transmitted 
predominantly by sexual contact and caused by a wide 
range of bacterial, viral, protozoa, fungal agents, and 
ectoparasites. (Anderson, 1991).
 
Worldwide more than 
340 million cases of sexually transmitted infections occur 
annually in adults aged 15-49 years. These infections 
are common in sexually active adolescents and young 
adults (WHO, 1981). Women and infants bear the brunt 
of  complications  such  as  still birth, ectopic  pregnancy,  
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infertility and ophthalmic neonatorium (WHO, 2001). 
Most infected women are asymptomatic and therefore 
fail to seek timely treatment (Bogaerts et al., 1999; 
Hawkes et al., 2000; Wassertheit et al., 1989; 
Wassertheit, 1989). The true incidence of STIs will is 
often not known not only because of inadequate 
reporting systems in most developing countries but 
because of the secrecy that surrounds them and many 
of them are not even notifiable (WHO, 1981). 
Chlamydia infection is a common STI in humans 
caused by the bacterium Chlamydia trachomatis.  
Chlamydia trachomatis is gram-negative, obligate 
intracellular bacterium pathogens of prokaryotic cells 
and are differentiated from other bacterial by their 
morphology and a unique developmental cycle  involving  
 
 
 
 
two morphological forms; one adapted to extracellular 
survival by multiplication within cytoplasmic vesicles. 
They are widely distributed in nature and are responsible 
for a variety of ocular, genitor-urinary and respiratory 
diseases in man (Jawetz et al., 2004). So far, 15 
immunotypes of Chlamydia trachomatis have been 
identified, eight of which are responsible for genital tract 
infections, three others for lymphogranuloma venerum 
associated with genital ulcer disease in tropical countries 
and the remaining four produce trachoma (McGregor 
and French, 1987). The prevalence of Chlamydia 
infection varies from place to place but there was an 
estimated 90 million cases of infection globally in 2001 
and approximately 4 million cases of Chlamydia infection 
are reported per year in the United States of America 
(USA), with an overall prevalence of 5 percent (WHO, 
2001; Wein et al., 2004; CDC, 2009). In Ethiopia the 
prevalence rate for Chlamydia infection of the cervix was 
5.9% and also a prevalence rate of 13.3% was noted 
among unsuspecting women attending antenatal clinic in 
Benin City Nigeria (Buve et al., 2001; Isibor et al., 2005). 
Nwanguma et al., (2009) reported a prevalence of 33% 
in asymptomatic volunteers in a population of Nigerians 
living in two cities in the South Eastern part of the 
country. Also in Anambra State, South East, Nigeria, the 
prevalence among tertiary school students and that 
found among infertile couples were 6.0% and 28.2% 
respectively,
 
while it was 29.4% in both students and 
non-students in another study done in Enugu State 
Nigeria (Chukwuma, 2005; Anahalu, 2006; Ikeme et al., 
2011). Genital Chlamydia infections are often chronic 
and asymptomatic, leading to severe complications 
including pelvic inflammatory disease, ectopic pregnancy 
and infertility (Daville, 2000).  
Herpes simplex virus types 1 and 2 (HSV-1 and 
HSV-2) are enveloped DNA viruses of the viral family 
herpesviridae. Genital herpes may be caused by either 
herpes virus type 1 or type 2 but globally, the large 
majority of cases are caused by HSV-2. The estimated 
number of people aged 15-49 years who were living with 
HSV-2 worldwide in 2003 was 536 million, or roughly 
16% of the world population in this age group. More 
women than men were infected with an estimated 315 
million infected women compared to 221 million infected 
men. The estimated number of new HSV-2 infections 
among 15-49 year olds worldwide in 2003 was 23.6 
million, of which 12.8 million were women and 10.8 
million were men. The number of new infections was 
highest in the youngest age groups and declined 
thereafter due to decline in the number of susceptibles 
(Katharine et al., 2008). 
In the USA about 50 million people have genital 
HSV and 26% of women have antibodies to HSV-2 
(Fleming et al., 1997; CDC, 2007). The prevalence 
estimates by region were highly heterogeneous. The 
prevalence of HSV-2 was generally higher in developing 
region than in developed regions. It is a common 
infection  in  many  countries,  with  prevalence  in  some  
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regions such as sub-Saharan Africa ranging from 30 to 
80% in women and from 10% to 50% in men (Weiss, 
2004). Most data in Central and South America are from 
women, in whom HSV-2 prevalence ranges from about 
20-40%. Prevalence in the general population in 
developing Asian countries appears to be lower, (10-
30%). The lowest prevalence was in Western Europe, 
where prevalence reached a maximum of around 18% 
among women and 13% among men.  Historically most 
genital infections have been caused by HSV-2 but 
however there is considerable overlap and the virus can 
be transmitted by masturbation, oro-genital contact, or 
poor hygiene. It has also been reported that 30-40% of 
genital infections and up to 80% of new genital infections 
are caused by HSV-1 (Lafferty et al., 2000). Factors that 
contribute to differences in prevalence by region for 
herpes are likely to be similar to those for Human 
immunodeficiency virus (HIV). These may include 
regional differences in the frequency and pattern of 
sexual risk behavior including rates of oral versus 
vaginal sex, differences in age at first sex, differences in 
the prevalence of sexually transmitted infections, co-
factors for HSV-2 and transmission such as HIV and 
differences in the structure of sexual networks                  
(Anderson et al., 1991; Garnet and Anderson, 1993; 
Morris et al., 1996; Morris and Kretzschmar, 1997; Wald 
and Link, 2002; Drain et al., 2004; Pettifor et al., 2004; 
Kaestle et al., 2005)   In contrast, genital herpes due to 
HSV-1 is of significant public-health importance but the 
inability of seroprevalence studies to distinguish between 
the two infection sites means it is much more difficult to 
generate estimates of the burden of genital HSV-1 
infection (Christie et al., 1997;  Löwhagen et al., 2002; 
Scouler et al., 2002; Roberts et al.,2003; Scrutt et 
al.,2003, Lafferly et al., 2003). Despite the typically 
asymptomatic nature of HSV which facilitate its spread in 
the population, it is a useful marker of sexual behavior, 
and it is associated with considerable morbidity and 
even mortality especially in pregnancy and in infancy. 
Neonatal infection can be very serious (Cowan et al., 
1994; Brown et al., 1997; Brown, 2004). In general HSV 
seroprevalence is high in populations whose behavior 
leads to a high risk of acquiring STIs, such as STI clinic 
attendees and sex works, with some studies reporting 
greater than 80% HSV seropositivity in sex workers 
(Weiss, 2004). Moreover, areas with high HSV-2 
prevalence commonly have a high prevalence of other 
sexually transmitted infections, such as Chlamydia and 
gonorrhea (WHO, 2001). Just as reported among other 
STIs, several studies have shown that Chlamydia 
trachomatis and HSV co-infections occur in vivo 
(Raavonen et al., 1985, Tait et al., 1985). Reports on 
Chlamydia trachomatis co-infection have indicated that 
HSV-2 co-infection alters Chlamydia development 
leading to persistence in host cells with subsequent 
attendant problems; however reviewed studies did not 
examine the co-infection process in details (Pontefract et 
al., 1989;  Chiarini,  et  al.,  1996;  Superti  et  al.,  2001).  
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Thus the aim of this study is to assess if the co-
existence between the two organisms exist in our 
environment. There is dearth of such findings in our 
study area. Therefore this study could help guide other 
researchers in conducting further studies on the 
prevalence and co-existence of both organisms 
especially in our environment. 
 
 
MATERIALS AND METHODS 
 
Study area 
 
This study was carried out among students in a tertiary 
institution in Anambra State, South East, Nigeria. 
Anambra State has a total population of about 4.7 million 
and invariable one of the most populous states in the 
south eastern part of Nigeria with a population growth 
rate of 3.0 from 1999 till date. The state is the 
commercial hub of the south east, and also one of the 
top most commercial states in Nigeria. There are many 
tertiary institutions in the state which consist of four 
Universities (two public and two private), two colleges of 
education, two polytechnics and five recognized school 
of nursing and midwifery among others. Nnamdi Azikiwe 
University is a federal institution with its main campus 
located at the state capital, Awka and has two other 
campuses in Nnewi and Agulu in the same state. 
 
 
Study design and sample size estimation 
 
This study is a cross sectional descriptive study of the 
seroprevalence and co-existence of Chlamydia 
trachomatis and HSV antibodies among students in a 
tertiary institution in Anambra State, Nigeria. The study 
population consisted of both male and female students 
from the selected tertiary institution. Using the Cochrane 
formula for sample size estimation for cross sectional 
studies and the sero-prevalence of Chlamydia 
trachomatis among tertiary students reported earlier in 
the state, 6.0%, the sample size that was used for this 
study was 88 students (Chukwuma, 2005) 
n    =    Z
2
pq  
             d
2
 
Where n= sample size to be estimated, z= the 
standard normal deviate corresponding to level of 
significance at 95% (≈1.96), p=the prevalence 
rate=6.0%, d=the degree of accuracy desired, set at 
0.05 or 95%. 
 
 
Sampling technique 
 
The sampling technique was multistage sampling 
technique; 
Stage 1 involved the selection of Nnamdi Azikiwe 
University from the list of tertiary institutions in  Anambra 
 
 
 
 
State, using simple random sampling by balloting. 
Stage II involved the selection of faculties to be 
studied of which faculties of education and social 
sciences were selected using simple random sampling 
by balloting  
Stage III which was the last stage involved the 
selection of respondents to be studied. Forty four 
students each from the faculties were selected using 
quota sampling.   
 
 
Materials used and test procedure 
 
A semi structured questionnaire was used to obtain 
information on the socio-demographic characteristics of 
respondents and their sexual behaviours. Blood was 
collected aseptically from consenting individuals who 
met the inclusion criteria by venepuncture, was allowed 
to cloth and serum was separated by centrifugation at 
room temperature and capped in non-sterile serum 
containers, stored at -20
0
C. Materials used for the study 
included; IgG serodiagnostic kit for both organisms, a 
micro plate calibrated reader, manual and automatic 
equipment for rinsing, vortex tube mixer, deionized 
water, timer, absorbent paper springs, gloves, serum 
collection bottles and test tubes. The Chlamydia 
trachomatis and HSV IgG kits (by DRG instruments 
GmBH, Germany) were used.  
 
 
Limitations 
 
This study was conducted in only one tertiary institution 
in the state, so caution should be taken in generalizing 
the findings. This can be regarded as a baseline study 
as only few works have been done in this sub-region to 
assess the co-existence of Chlamydia trachomatis and 
HSV 
 
 
RESULTS  
 
Most of the participants were more than 24 years of age 
(51.1%) with a mean age of 24.2 5.6 years. Seventy 
percent of the respondents were females with majority of 
them being singles, (88.6%) and living off campus, 
(80.7%) Table1. 
Table 2 showed that about eighty-two percent of the 
respondents have had penetrative vaginal/penile sexual 
intercourse before, of this number, 84.7% of students 
claimed to have had at least an unprotected sexual 
intercourse in the last one year preceding the survey. 
Most of them, 68.1%, had sex within the same period 
with at least 2 or more sexual partners. Almost seventy 
percent of students have had symptoms suggestive of 
sexually transmitted infections, with forty one percent     
of them having multiple symptoms  at  presentation.  The  
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Table 1. Socio-demographic characteristics of participants 
 
Socio demographic characteristics  Frequency (n=88) % 
Age group (years) 
15-24 
  > 24 
Total 
Mean age 24.2 5.6yrs 
 
43 
45 
88 
 
48.9 
51.1 
100.0 
Sex  
Male 
Female 
Total 
 
26 
62 
88 
 
29.5 
70.5 
100.0 
Marital Status 
Married 
Single 
Total 
 
10 
78 
88 
 
11.4 
88.6 
100.0 
Place of Residence 
Off campus 
School Hostel 
Living with parents/relatives 
Total 
 
71 
5 
12 
88 
 
80.7 
5.7 
13.6 
100.0 
 
 
Table 2. Sexual behaviours of participants and symptoms suggestive of STI 
 
Variable  Frequency % 
Ever had penetrative sexual intercourse before (Vaginal/penile) n=88 
Yes 
No 
Total 
72 
16 
88 
81.9 
18.1 
100.0 
Had unprotected sexual intercourse in the last 1 year n=72 
Yes 
No 
Total 
61 
17 
72 
84.7 
15.3 
100.0 
Number of sexual partners in the last 1 year n=61 
1 
>2 
Total 
19 
42 
61 
31.1 
68.8 
100.0 
Ever had symptoms suggestive of STI n=88 
Yes 
No 
Total 
61 
27 
88 
69.3 
31.7 
100.0 
Had more than one symptom at presentation n=61 
Yes 
No 
Total 
25 
36 
61 
41.0 
59.0 
100.0 
Types of symptoms mentioned (multiple response) n=61 
Itching 
Lower abdominal pain 
Rashes  
Discharge 
Sores 
Dysuria 
Severe menstrual pain  
Others  
39 
23 
20 
18 
8 
4 
3 
3 
63.9 
37.7 
32.8 
29.5 
13.3 
6.5 
4.9 
4.9 
Others inability to conceive, low sexual performance. 
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Table 3. Seroprevalence prevalence of Chlamydia trachomatis and HSV antibodies 
 
Test Result Frequency (n=88) % 
Chlamydia trachomatis antibody seroprevalence 
Positive 
Negative 
Total 
 
19 
69 
88 
 
21.6 
78.6 
100.0 
HSV antibody seroprevalence 
Positive 
Negative 
Total 
 
24 
64 
88 
 
27.3 
72.7 
100.0 
 
 
 
commonest symptoms of STI that the students had 
were; itching of the private part, (63.9%), lower 
abdominal pain, (37.7%), rashes, (32.8%), and 
vaginal/penile discharge, (29.5%).  
The seroprevalence of HSV infection, 24(27.3%) 
was found to be slightly higher than that of chlamydia 
trachomatis, 19(21.6%), among the study participants, 
this difference was not statistically significant, (p=0.380, 
p>0.05). Table 3  
Also more students were positive to HSV antibodies 
only, 16(18.2%) when compared to Chlamydia 
trachomatis antibodies only, 11(12.5%), with eight 
participants, 8(9.5%) being seropositive for both 
organisms. (Figure 1)  
 The seroprevalence of Chlamydia trachomatis in 
those that were positive to HSV antibodies was slightly 
higher than their counterpart with negative HSV 
antibodies, (33.3% versus 17.2%), similarly the 
seroprevalence of HSV antibodies was higher in those 
with positive Chlamydia antibodies, than their 
counterparts with negative Chlamydia trachomatis 
antibodies, (42.1% versus 23.2%). These differences 
were not statistically significant, p>0.05. Table 4   
Table 5 showed that antibody titres to both 
Chlamydia trachomatis and HSV were higher among 
those who have had sexual intercourse before, (26.4% 
and 33.3%), had unprotected sexual intercourse in the 
last 1 year preceding the study, (29.5% and 37.7%), and 
also among those who have 2 or more sexual partners 
one year prior to survey, (35.7% and 42.9%) than their 
counterparts without such sexual history. These 
differences were statistically significant, p<0.05. 
 
 
DISCUSSION 
 
The mean of participants in this study was 24.2 6.6 
years which fall within the age of youths and young 
adults (WHO, 1981, 2001). Sexual activity and risky 
sexual behaviours were found to be high among the 
students studied with a high proportion of them having 
penetrative vaginal/penile, unprotected sexual 
intercourse, and sex with multiple partners. This pattern 
of risky sexual behaviours has been widely reported 
among adolescent and young adults in many studies 
(WHO, 2001; Hardick et al., 2003; Duru et al., 2010). 
Despite wide spread enlightenment campaigns on safe 
sex, these risky behaviours have remained prevalent 
and there is decreasing age at initiation of sex in most 
countries of the world (Isibor, 2005). This could likely 
account for large burden of sexually transmitted 
infections reported in this age group. The issue is that 
the world has been made a global village due to easy 
accessibility to information technology that had made 
communication very easy and a large proportion of our 
young adults’ access wrong information about sexuality 
and related practices from many sites in the internet. 
This coupled with their risky behaviours is posing a 
threat to this group of people and the world at large. 
The prevalence of HSV was found to be 27.3%, this 
is within the range reported in sub-Saharan African 
which ranges from 30-80% in women and 10-50% in 
men (Weiss, 2004).  It also within the range found in 
South America, (20-40%) and Asia, (10-30%) but lower 
than the average in Europe, 13% and 18% for men and 
women respectively (Lafferty et al 2000). These wide 
variations are due to differences in frequency and 
pattern of risky sexual behaviours including rate of oral 
versus vaginal sex, differences in age at first sex, 
differences in sexually transmitted infection and the 
structure of sexual networks. Also the general HSV 
seroprevalence has been reported to be high in 
population whose behaviour leads to a high risk of 
acquiring other sexually transmitted infections, and this 
was noted in our study where risky sexual behaviours 
among respondents were prevalent (Weiss, 2004). 
The prevalence of Chlamydia trachomatis antibodies 
in this survey was 21.6%. There is a wide variation in the 
incidence and prevalence of Chlamydia trachomatis 
globally and this variation depends on the age, marital 
status, clinical condition, sensitiveness of the methods 
used and other various factors (Ikeme et al., 2011; Buve 
et al., 2001). This finding was higher than earlier report 
from students in this same institution, which was 6.0%, 
(Chukwuma, 2005)  also higher than reports from Benin 
city, Nigeria, 13.3%, (Isibor, 2005)  among unsuspecting 
women attending ANC in Ethiopia, 5.9%, (Buve et al., 
2001)  and reports  from USA, which stood at  an  overall  
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Figure 1. Co-existence of antibodies to both organisms 
 
 
Table 4. Comparison of seroprevalence of both organisms in those with positive and negative results to each of them. 
 
Chlamydia trachomatis Positive (%) Negative (%) Total (% 
HSV     
Positive 
Negative 
Total 
8(33.3) 
11(17.2) 
19(21.6) 
16(66.7) 
53(82.8) 
69(78.4) 
24(100.0) 
64(100.0) 
88(100.0) 
HSV  Positive (%) Negative (%) Total (%) 
Chlamydia trachomatis  
Positive 
Negative 
Total 
 
8(42.1) 
16(23.2) 
24(27.3) 
 
11(57.9) 
53(76.8) 
64(72.7) 
 
19(100.0) 
69(100.0) 
88(100.0) 
χ
2
=2.69, df=1, p=0.101    
 
 
Table 5. Sexual behavior of partcipants and pattern of seropositivity 
 
 Chlamydia trachomatis HSV 
Variable +ve(%) -ve(%) Total(%) +ve(%) -ve(%) Total(%) 
Ever had sexual intercourse before 
Yes 
No 
Total 
19(26.4) 
0(0.0) 
19(21.6) 
53(73.6) 
16(100.0) 
69(78.4) 
72(100.0) 
16(100.0) 
88(100.0) 
24(33.3) 
0(0.0) 
24(27.3) 
48(66.7) 
16(100.0) 
64(72.7) 
72(100.0) 
16(100.0) 
88(100.0) 
 F=5.38, df=1, p=0.013* F=7.33, df=1, p=0.003* 
Had unprotected sexual intercourse in the last 1 year 
Yes 
No 
Total 
18(29.5) 
1(3.7) 
19(21.6) 
43(70.5) 
26(96.3) 
69(78.4) 
61(100.0) 
27(100.0) 
88(100.0) 
23(37.7) 
1(3.7) 
24(27.3) 
38(68.3) 
26(96.3) 
64(72.7) 
61(100.0) 
27(100.0) 
88(100.0) 
 F=7.36, df=1, p=0.004* F=10.90, df=1, p=0.000* 
No of sexual partners in the last one year 
0-1 
≥2 
Total  
4(8.70) 
15(35.7) 
19(21.6) 
42(91.3) 
27(64.3) 
69(78.4) 
46(100.0) 
42(100.0) 
88(100.0) 
6(13.0) 
18(42.9) 
24(27.3) 
40(87.0) 
24(57.1) 
64(72.7) 
46(100.0) 
42(100.0) 
88(100.0) 
 F=9.46, df=1, p=0.002* χ
2
=9.83, df=1, p=0.003* 
 
*= Significant. F= Fishers exact.  
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prevalence of 5.0% (Wein et al.,2004, CDC, 2009). It 
was within the range found among patients attending 
family planning clinics in correctional facilities in the UK 
and another report from Ibadan Nigeria (Darogar et al., 
1990; LaMontagne et al., 2004). It was observed to be 
lower than figures reported from Anambra state among 
infertile couples, 28.3%, (Anahalu, 2006) and Enugu 
among students and non-students, 29.4% (Ikeme et al., 
2011). It is also lower than figures reported by 
Nwanguma et al., (2009) in two Nigeria cities which 
showed the seroprevalence of Chlamydia trachomatis to 
be 33.0% among volunteers with unknown HIV status, 
and 50% among HIV positive patients. The prevalence 
of chlamydia trachomatis has been reported globally      
to be high among young population; this is consistent 
with findings in this study. This may indicate high    
sexual activity, multiple sexual partners and low            
use of barrier (condom) methods of contraception     
which is prevalent in this group and was shown in this 
survey. 
There was evidence of co-infection of Chlamydia 
trachomatis and HSV infection antibodies in this study as 
shown by, 9.6% of the total having antibodies to both 
organisms. Also found in the study is the complimentary 
nature of antibodies to both organisms. Co-existent of 
sexually transmitted of sexually transmitted disease 
have been widely reported (Raavonen et al., 1985; Tait 
et al., 1985; Wasserheit, 1989; Bogarts et al., 2000; 
WHO, 1981, 2001; Superti et al., 2001; Wein et al., 
2004).  The postulated reason are simple, they all have 
one main route of transmission which is sexual contact, 
so risky behaviours can expose one to multiple 
infections easily, also some of the organism             
cause inflammation of the mucosal layers of the       
genital tract, distorting its integrity, thereby enhancing 
access into the genital tract tissues by other organ-    
isms. Also some molecular explanations have           
been suggested for chronicity and persistence of 
infections. In this survey, the simple explanation is       
likely that of risky sexual behaviours noticed           
among participants and this finding was strengthened by 
higher prevalence rates found among those with known 
risky sexual behaviors. This finding of higher 
seroprevalences to STIs among individuals with high risk 
sexual behaviours have been reported in several studies 
(Buve et al., 2001; CDC, 2009; Nwanguma et al., 2009; 
Ikeme et al., 2011).
 
Despite wide spread public 
enlightenment from several sources, sexually 
transmitted diseases are on the rise, especially in under 
developed countries where the burden of the disease is 
worse. 
 
 
CONCLUSION 
 
This study revealed a high prevalence of antibodies to 
both organisms with some level of co-infection noticed, 
and   prevalence  to  both  organisms   was   significantly  
 
 
 
 
higher among those with some form of risky sexual 
behaviours. This is of grave public health  importance  to 
the nation and region at large as sexually transmitted 
diseases are communicable and can cause both acute 
and chronic complications even in the absence of 
obvious symptoms. In-depth research papers on this co-
existence in the country and region are low when 
compared to volume of research papers from developed 
countries. Infection by these organisms can be reduced 
to the barest minimum if adequate control measures are 
strictly implemented as this has been achieved in most 
developed countries. Thus, there is need to sustain, 
improve and expand the existing mass enlightenment 
campaigns on the consequences of unprotected sexual 
intercourse. Evidence based research even at molecular 
and genetic levels should be financed in poorly 
developed nations, to ascertain the true picture of the 
burden of these diseases and their existence together 
with others, and proffer the appropriate treatment 
needed even in resistance cases. The tests for         
these organisms should be made available in our 
hospitals by authorities concerned and free of charge 
especially to the sexually active adolescent and young 
adults. 
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